Search
Results: 2
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19
Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Yi Hu, Zhenshun Cheng, Ling Gao, Yang Jin, Guangwei Luo, Shouzhi Fu, Qiaofa Lu, Guanhua Du, Ke Wang, Yang Lu, Guohui Fan, Yi Zhang, Ying Liu, Shunan Ruan, Wen Liu, Thomas Jaki, Frederick G Hayden, Peter W Horby, Bin Cao, Chen Wang
Jul 16, 2020
BACKGROUND: Coronavirus disease 2019 (COVID-19), caused by a novel corinavirus (later named SARS-CoV-2 virus), was fistly reported in Wuhan, Hubei Province, China towards the end of 2019. Large-scale spread within China and...
Administrative information antiviral covid-19 China clinical trial Remdesivir Adenosine Monophosphate Alanine Antiviral Agents Betacoronavirus covid-19 China Clinical Trials Phase III as Topic Coronavirus Infections Double-Blind Method Equivalence Trials as Topic Female Humans Infusions Intravenous Male Multicenter Studies as Topic Pandemics Patient Safety Pneumonia Viral Risk Assessment Risk Factors SARS-CoV-2 Severity of Illness Index Time Factors Treatment Outcome COVID-19 Drug Treatment
Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients.
Florencia AT Boshier, Juanita Pang, Justin Penner, Matthew Parker, Nele Alders, Alasdair Bamford, Louis Grandjean, Stephanie Grunewald, James Hatcher, Timothy Best, Caroline Dalton, Patricia Dyal Bynoe, Claire Frauenfelder, Jutta Köeglmeier, Phoebe Myerson, Sunando Roy, Rachel Williams, Thushan I de Silva, Richard A Goldstein, Judith Breuer, COVID-19 Genomics UK (COG-UK) Consortium
Sep 05, 2021
SARS-CoV-2 intrahost Remdesivir viral-variants Adenosine Monophosphate Adolescent Alanine Antiviral Agents covid-19 Child Child Preschool Drug Resistance Viral evolution Molecular Female Haplotypes Humans Infant Lung Male Phylogeny RNA Viral SARS-CoV-2 Viral Load Virus Replication COVID-19 Drug Treatment